Pyrimethamine Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029
The global pyrimethamine market is expected to grow at a significant CAGR during the forecast period. Pyrimethamine is a protozoan infection treatment drug. It's frequently used as an antimalarial medication (for both treatment and prevention of malaria) as well as to treat Toxoplasma gondii infections, especially when coupled with the sulfonamide antibiotic sulfadiazine in HIV-positive patients. Owing to its resistance to several plasmodium species, pyrimethamine is usually combined with sulfonamide and folinic acid. Pyrimethamine has also been shown to suppress the expression of the superoxide dismutase 1 gene, which is linked to amyotrophic lateral sclerosis.
Pyrimethamine is a folic acid
antagonist that is used as an antimalarial or in combination with a
sulphonamide to treat toxoplasmosis. Pyrimethamine prevents the production of
purines and pyrimidines, which are required for DNA synthesis and cell
proliferation, by inhibiting plasmodia dihydrofolate reductase. Nuclear
division failure occurs during schizont development in erythrocytes and the
liver as a result of this process. It's often utilized as a supplement in the
treatment of uncomplicated P. falciparum malaria that's resistant to
chloroquine.
According to the World Health Organization's (WHO)
"World Malaria Report 2018," there were an estimated 219 million
cases and over 435,000 mortalities from malaria in 2017, with Plasmodium
falciparum accounting for the majority of cases. As a result, the increased
prevalence of malaria is driving this market growth. Pyrimethamine is on the
WHO’s list of essential medicines as one of the most critical drugs. The
potential of pyrimethamine to cure protozoan and toxoplasma infections, as well
as the growing number of HIV-positive patients globally and immunosuppressed
individuals at risk of infections, are driving the market growth during the
forecast period.
Pyrimethamine Tablets USP, 25 mg, a therapeutic
equivalent and first-wave generic version of Daraprim (pyrimethamine) Tablets,
was launched by Dr. Reddys Laboratories and was authorized by the US Food and
Drug Administration (USFDA) in March 2020. The USFDA has authorized this
generic version of Daraprim (pyrimethamine) Tablets as the sole AB-rated
generic version of Daraprim (pyrimethamine) Tablets.
To Request a Sample of our Report on Pyrimethamine
Market: https://www.omrglobal.com/request-sample/pyrimethamine-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2023-2030
Segment Covered-
·
By Type – Tablets, Capsules,
Injectables
·
By Drug – Daraprim and Fansidar
·
By End-User vertical –
Hospitals and Clinics, Laboratories, and Others
Competitive Landscape: Evaluate, Pfizer Inc., Pfizer Inc. GlaxoSmithKline plc.,
and others.
Pyrimethamine Market Report
By Type
·
Tablets
·
Capsules
·
Injectables
By Drug
·
Daraprim
·
Fansidar
·
By End-User vertical
·
Hospitals and Clinics
·
Laboratories
·
Others
A full
Report of Pyrimethamine Market is Available @ https://www.omrglobal.com/industry-reports/pyrimethamine-market
Regional Analysis
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/pyrimethamine-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment